The costs and benefits of psychedelics on cognition and mood
Neuron · 2023-03 · 111 (5) · 614-630
DOI: 10.1016/j.neuron.2022.12.031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuron, 2023-03. Verfasst von Ceyda Sayalı und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Bal…. Hauptthemen laut MEDLINE: Hallucinogens. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 182 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. Electronic address: zsayali1@jh.edu.
- Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA; Department of Neuroscience, Johns Hopkins Unive…
Zitieren
APA
Sayalı, C., & Barrett, F. S. (2023). The costs and benefits of psychedelics on cognition and mood. Neuron, 111(5), 614-630. https://doi.org/10.1016/j.neuron.2022.12.031
Vancouver
Sayalı C, Barrett FS. The costs and benefits of psychedelics on cognition and mood. Neuron. 2023;111(5):614-630. doi:10.1016/j.neuron.2022.12.031
BibTeX
@article{Sayal2023,
author = {Sayalı, Ceyda and Barrett, Frederick S},
title = {The costs and benefits of psychedelics on cognition and mood},
journal = {Neuron},
year = {2023},
volume = {111},
number = {5},
pages = {614--630},
doi = {10.1016/j.neuron.2022.12.031}
}
EUVIMED